Trinity Biotech plc each representing 4 A Ordinary Shares (TRIB) Social Stream

Featured Post From StockTwits About TRIB

$TRIB
CODX

Operating income down 19.8%
• Operating income totaled $11.8 million, representing a 19.8% decrease from the prior year period due to increased sales and marketing expenses as a result of increased third-party sales commissions, as well as increased research and development expenses related to the Eikon point of care technology platform.

Net income down 34%
• Net income of $9.8 million, compared to a net income of $15.0 million in the prior-year first quarter, representing $0.33 per fully diluted share, as compared to $0.51 per fully diluted share in the second quarter of 2020.